E-LIB Suche - Ergebnisse für: Steenbergen, Judith N.

1

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses ..:

Bhavnani, Sujata M. ; Hammel, Jeffrey P. ; Lakota, Elizabeth A....
Antimicrobial Agents and Chemotherapy. 67 (2023) 4 - p. , 2023

Link: https://doi.org/10.1128/..

2

Omadacycline vs moxifloxacin in adults with community-acqui..:

Torres, Antoni ; Garrity-Ryan, Lynne ; Kirsch, Courtney...
International Journal of Infectious Diseases. 104 (2021) - p. 501-509 , 2021

Link: https://doi.org/10.1016/..

3

Pharmacokinetic-Pharmacodynamic Characterization of Omadacy..:

VanScoy, Brian D. ; Lakota, Elizabeth A. ; Conde, Haley...
Antimicrobial Agents and Chemotherapy. 64 (2020) 6 - p. , 2020

Link: https://doi.org/10.1128/..

4

Population Pharmacokinetic Analyses for Omadacycline Using ..:

Lakota, Elizabeth A. ; Van Wart, Scott A. ; Trang, Michael...
Antimicrobial Agents and Chemotherapy. 64 (2020) 7 - p. , 2020

Link: https://doi.org/10.1128/..

5

734. Modeling the Pharmacokinetics and Pharmacodynamics of ..:

Friedrich, Lawrence ; Curran, Marla ; Chitra, Surya...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S329-S329 , 2019

Link: https://doi.org/10.1093/..

6

733. Pharmacokinetic–Pharmacodynamic (PK–PD) Analyses for A..:

Bhavnani, Sujata M ; Trang, Michael ; George, Darryl R...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S328-S329 , 2019

Link: https://doi.org/10.1093/..

7

1561. Omadacycline Pharmacokinetics: Influence of Mortality..:

Lakota, Elizabeth A ; Friedrich, Lawrence ; Steenbergen, Judith N...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S569-S570 , 2019

Link: https://doi.org/10.1093/..

8

1347. Omadacycline for Acute Bacterial Skin and Skin Struct..:

Abrahamian, Fredrick M ; Sakoulas, George ; Tzanis, Evan...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S412-S412 , 2018

Link: https://doi.org/10.1093/..

9

1364. Efficacy of Omadacycline Against Molecularly Characte..:

Mendes, Rodrigo E ; Castanheira, Mariana ; Armstrong, Eliana S..
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S417-S418 , 2018

Link: https://doi.org/10.1093/..

10

1377. Omadacycline In Vitro Activity Against a Molecularly ..:

Mendes, Rodrigo E ; Castanheira, Mariana ; Armstrong, Eliana S..
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S422-S422 , 2018

Link: https://doi.org/10.1093/..

11

A Phase 3 Randomized, Double-blind, Multi-center Study to C..:

Stets, Roman ; Popescu, Monica ; Gonong, Joven...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S543-S544 , 2017

Link: https://doi.org/10.1093/..

12

A Pharmacometric Comparison of Omadacycline and Tigecycline..:

Lakota, Elizabeth A ; Rodvold, Keith A ; Bhavnani, Sujata M...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S529-S530 , 2017

Link: https://doi.org/10.1093/..

13

Analysis of the Microbiological data from the Omadacycline ..:

Armstrong, Eliana ; Tzanis, Evan ; Manley, Amy...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S540-S540 , 2017

Link: https://doi.org/10.1093/..

14

In vitro pharmacodynamic evaluation of ceftolozane/tazobact..:

Soon, Rachel L. ; Lenhard, Justin R. ; Bulman, Zackery P....
International Journal of Antimicrobial Agents. 49 (2017) 1 - p. 25-30 , 2017

Link: https://doi.org/10.1016/..

15

Efficacy of ceftolozane/tazobactam against urinary tract an..:

Popejoy, Myra W. ; Paterson, David L. ; Cloutier, Daniel...
Journal of Antimicrobial Chemotherapy. 72 (2016) 1 - p. 268-272 , 2016

Link: https://doi.org/10.1093/..